We are monitoring the impact of COVID-19 on Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 1125
Share on
Share on

Global Autoimmune Diagnostics Market Analysis – By Test Type, Disease Type, End User and Region - Industry Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast | 2019 - 2024

Pulished: August, 2019
ID: 1125
Pages: 182

Autoimmune Diagnostics Market Size & Growth (2019 - 2024)

The size of the Global Autoimmune diagnostics Market was worth USD 14.03 billion in 2019 and estimated to reach USD 16.74 billion by the end of 2024 with a growth potential of 3.6% during the forecast period 2019 - 2024.

Autoimmune disease is a disorder where the patient’s immune system attacks own body tissues that led to the damage of body organs. Nearly 80 types of autoimmune diseases are known so far.

The Global Autoimmune diagnostics market is expected to show tremendous growth due to Mergers & acquisitions between research institutes and companies. Increasing advancements in new technologies and services are expected to increase the Point of care tests which will change the dynamics of the market over the forecast period. The most common autoimmune diseases include Graves’ disease, rheumatoid arthritis, Hashimoto’s thyroiditis, type1 diabetes, multiple sclerosis, and systemic lupus erythematosus.

Recent discoveries in autoimmune disease diagnostic techniques, upgraded laboratory techniques, increasing public awareness for autoimmune disorders and automation are the major factors driving the growth of the market.

The key restraints that inhibiting the growth of the autoimmune diagnostics market are Competitive pricing among the major manufacturers, unavailability of skilled manpower and growing demand for innovative technological products.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Test Type, Disease Type & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly and GlaxoSmithKline Plc.

 

This research report on the Global Autoimmune Diagnostics Market has been segmented and sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.

Autoimmune Diagnostics Market Analysis - By Test Type

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Complete Blood Count (CBC)
  • C-reactive protein (CRP) 
  • Comprehensive Metabolic panel   
  • Urinalysis 
  • Erythrocyte Sedimentation Rate (ESR)        
  • Others

Autoimmune Diagnostics Market Analysis - By Disease Type

  • Localized autoimmune disease diagnostics
    • Graves' Disease
    • Hashimoto's Thyroiditis
    • Multiple Sclerosis
    • Type 1 diabetes
    • Psoriasis
    • Others
  • Systemic autoimmune disease diagnostics
    • Rheumatoid Arthritis (RA)
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)

Autoimmune Diagnostics Market Analysis - By End User:

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories

Regional Analysis:

North America dominates the global autoimmune diagnostics market with the highest share followed by Europe, Asia Pacific. The Asia-pacific market is expected to account for the highest growth during the forecast period.

Key market participants leading the Global Autoimmune Diagnostics Market profiled in the report are:

  1. Bio-Rad
  2. Siemens Healthcare
  3. Abbott Laboratories
  4. Crescendo Bioscience
  5. Roche Diagnostics SQI Diagnostics
  6. AESKU Diagnostics
  7. INOVA Diagnostics Inc.
  8. BioMerieux SA
  9. Beckman Coulter Inc.
  10. Hemagen Diagnostics
  11. Quest Diagnostics
  12. Eli Lilly
  13. GlaxoSmithKline Plc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                        

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Autoimmune diagnostics Market By Region, From 2019-2024 (USD Billion)
  2. Global Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  3. Global Autoantibody Tests Market By Region, From 2019-2024 (USD Billion)
  4. Global Antinuclear Antibody Tests Market By Region, From 2019-2024 (USD Billion)
  5. Global Complete Blood Count (CBC) Market By Region, From 2019-2024 (USD Billion)
  6. Global C - reactive protein (CRP) Market By Region, From 2019-2024 (USD Billion)
  7. Global Comprehensive Metabolic panel Market By Region, From 2019-2024 (USD Billion)
  8. Global Urinalysis Market By Region, From 2019-2024 (USD Billion)
  9. Global Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019-2024 (USD Billion)
  10. Global Other Test Types Market By Region, From 2019-2024 (USD Billion)
  11. Global Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  12. Global Localized Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  13. Global Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  14. Global Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  15. Global Graves' Disease Market By Region, From 2019-2024 (USD Billion)
  16. Global Hashimoto's Thyroiditis Market By Region, From 2019-2024 (USD Billion)
  17. Global Multiple Sclerosis Market By Region, From 2019-2024 (USD Billion)
  18. Global Type 1 diabetes Market By Region, From 2019-2024 (USD Billion)
  19. Global Psoriasis Market By Region, From 2019-2024 (USD Billion)
  20. Global Other Localized Autoimmune Diagnostics Market By Region, From 2019-2024 (USD Billion)
  21. Global Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  22. Global Rheumatoid Arthritis (RA) Market By Region, From 2019-2024 (USD Billion)
  23. Global Ankylosing Spondylitis Market By Region, From 2019-2024 (USD Billion)
  24. Global Systemic Lupus Erythematosus (SLE) Market By Region, From 2019-2024 (USD Billion)
  25. North America Autoimmune diagnostics Market By Region, From 2019-2024 (USD Billion)
  26. North America Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  27. North America Autoantibody Tests Market By Region, From 2019-2024 (USD Billion)
  28. North America Antinuclear Antibody Tests Market By Region, From 2019-2024 (USD Billion)
  29. North America Complete Blood Count (CBC) Market By Region, From 2019-2024 (USD Billion)
  30. North America C - reactive protein (CRP) Market By Region, From 2019-2024 (USD Billion)
  31. North America Comprehensive Metabolic panel Market By Region, From 2019-2024 (USD Billion)
  32. North America Urinalysis Market By Region, From 2019-2024 (USD Billion)
  33. North America Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019-2024 (USD Billion)
  34. North America Other Test Types Market By Region, From 2019-2024 (USD Billion)
  35. North America Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  36. North America Localized Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  37. North America Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  38. United States Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  39. United States Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  40. Canada Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  41. Canada Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  42. North America Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  43. North America Graves' Disease Market By Region, From 2019-2024 (USD Billion)
  44. North America Hashimoto's Thyroiditis Market By Region, From 2019-2024 (USD Billion)
  45. North America Multiple Sclerosis Market By Region, From 2019-2024 (USD Billion)
  46. North America Type 1 diabetes Market By Region, From 2019-2024 (USD Billion)
  47. North America Psoriasis Market By Region, From 2019-2024 (USD Billion)
  48. North America Other Localized Autoimmune Diagnostics Market By Region, From 2019-2024 (USD Billion)
  49. United States Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  50. Canada Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  51. North America Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  52. North America Rheumatoid Arthritis (RA) Market By Region, From 2019-2024 (USD Billion)
  53. North America Ankylosing Spondylitis Market By Region, From 2019-2024 (USD Billion)
  54. North America Systemic Lupus Erythematosus (SLE) Market By Region, From 2019-2024 (USD Billion)
  55. United States Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  56. Canada Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  57. Europe Autoimmune diagnostics Market By Region, From 2019-2024 (USD Billion)
  58. Europe Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  59. Europe Autoantibody Tests Market By Region, From 2019-2024 (USD Billion)
  60. Europe Antinuclear Antibody Tests Market By Region, From 2019-2024 (USD Billion)
  61. Europe Complete Blood Count (CBC) Market By Region, From 2019-2024 (USD Billion)
  62. Europe C - reactive protein (CRP) Market By Region, From 2019-2024 (USD Billion)
  63. Europe Comprehensive Metabolic panel Market By Region, From 2019-2024 (USD Billion)
  64. Europe Urinalysis Market By Region, From 2019-2024 (USD Billion)
  65. Europe Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019-2024 (USD Billion)
  66. Europe Other Test Types Market By Region, From 2019-2024 (USD Billion)
  67. Europe Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  68. Europe Localized Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  69. Europe Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  70. U.K Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  71. U.K Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  72. Spain Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  73. Spain Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  74. Germany Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  75. Germany Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  76. Italy Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  77. Italy Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  78. France Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  79. France Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  80. Europe Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  81. Europe Graves' Disease Market By Region, From 2019-2024 (USD Billion)
  82. Europe Hashimoto's Thyroiditis Market By Region, From 2019-2024 (USD Billion)
  83. Europe Multiple Sclerosis Market By Region, From 2019-2024 (USD Billion)
  84. Europe Type 1 diabetes Market By Region, From 2019-2024 (USD Billion)
  85. Europe Psoriasis Market By Region, From 2019-2024 (USD Billion)
  86. Europe Other Localized Autoimmune Diagnostics Market By Region, From 2019-2024 (USD Billion)
  87. U.K Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  88. Spain Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  89. Germany Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  90. Italy Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  91. France Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  92. Europe Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  93. Europe Rheumatoid Arthritis (RA) Market By Region, From 2019-2024 (USD Billion)
  94. Europe Ankylosing Spondylitis Market By Region, From 2019-2024 (USD Billion)
  95. Europe Systemic Lupus Erythematosus (SLE) Market By Region, From 2019-2024 (USD Billion)
  96. U.K Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  97. Spain Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  98. Germany Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  99. Italy Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  100. France Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  101. Asia-Pacific Autoimmune diagnostics Market By Region, From 2019-2024 (USD Billion)
  102. Asia-Pacific Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  103. Asia-Pacific Autoantibody Tests Market By Region, From 2019-2024 (USD Billion)
  104. Asia-Pacific Antinuclear Antibody Tests Market By Region, From 2019-2024 (USD Billion)
  105. Asia-Pacific Complete Blood Count (CBC) Market By Region, From 2019-2024 (USD Billion)
  106. Asia-Pacific C - reactive protein (CRP) Market By Region, From 2019-2024 (USD Billion)
  107. Asia-Pacific Comprehensive Metabolic panel Market By Region, From 2019-2024 (USD Billion)
  108. Asia-Pacific Urinalysis Market By Region, From 2019-2024 (USD Billion)
  109. Asia-Pacific Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019-2024 (USD Billion)
  110. Asia-Pacific Other Test Types Market By Region, From 2019-2024 (USD Billion)
  111. Asia-Pacific Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  112. Asia-Pacific Localized Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  113. Asia-Pacific Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  114. China Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  115. China Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  116. India Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  117. India Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  118. Japan Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  119. Japan Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  120. South Korea Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  121. South Korea Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  122. Australia Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  123. Australia Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  124. Asia-Pacific Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  125. Asia-Pacific Graves' Disease Market By Region, From 2019-2024 (USD Billion)
  126. Asia-Pacific Hashimoto's Thyroiditis Market By Region, From 2019-2024 (USD Billion)
  127. Asia-Pacific Multiple Sclerosis Market By Region, From 2019-2024 (USD Billion)
  128. Asia-Pacific Type 1 diabetes Market By Region, From 2019-2024 (USD Billion)
  129. Asia-Pacific Psoriasis Market By Region, From 2019-2024 (USD Billion)
  130. Asia-Pacific Other Localized Autoimmune Diagnostics Market By Region, From 2019-2024 (USD Billion)
  131. China Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  132. India Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  133. Japan Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  134. South Korea Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  135. Australia Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  136. Asia-Pacific Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  137. Asia-Pacific Rheumatoid Arthritis (RA) Market By Region, From 2019-2024 (USD Billion)
  138. Asia-Pacific Ankylosing Spondylitis Market By Region, From 2019-2024 (USD Billion)
  139. Asia-Pacific Systemic Lupus Erythematosus (SLE) Market By Region, From 2019-2024 (USD Billion)
  140. China Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  141. India Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  142. Japan Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  143. South Korea Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  144. Australia Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  145. Latin America Autoimmune diagnostics Market By Region, From 2019-2024 (USD Billion)
  146. Latin America Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  147. Latin America Autoantibody Tests Market By Region, From 2019-2024 (USD Billion)
  148. Latin America Antinuclear Antibody Tests Market By Region, From 2019-2024 (USD Billion)
  149. Latin America Complete Blood Count (CBC) Market By Region, From 2019-2024 (USD Billion)
  150. Latin America C - reactive protein (CRP) Market By Region, From 2019-2024 (USD Billion)
  151. Latin America Comprehensive Metabolic panel Market By Region, From 2019-2024 (USD Billion)
  152. Latin America Urinalysis Market By Region, From 2019-2024 (USD Billion)
  153. Latin America Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019-2024 (USD Billion)
  154. Latin America Other Test Types Market By Region, From 2019-2024 (USD Billion)
  155. Latin America Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  156. Latin America Localized Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  157. Latin America Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  158. Brazil Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  159. Brazil Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  160. Argentina Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  161. Argentina Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  162. Mexico Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  163. Mexico Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  164. Latin America Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  165. Latin America Graves' Disease Market By Region, From 2019-2024 (USD Billion)
  166. Latin America Hashimoto's Thyroiditis Market By Region, From 2019-2024 (USD Billion)
  167. Latin America Multiple Sclerosis Market By Region, From 2019-2024 (USD Billion)
  168. Latin America Type 1 diabetes Market By Region, From 2019-2024 (USD Billion)
  169. Latin America Psoriasis Market By Region, From 2019-2024 (USD Billion)
  170. Latin America Other Localized Autoimmune Diagnostics Market By Region, From 2019-2024 (USD Billion)
  171. Brazil Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  172. Argentina Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  173. Mexico Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  174. Latin America Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  175. Latin America Rheumatoid Arthritis (RA) Market By Region, From 2019-2024 (USD Billion)
  176. Latin America Ankylosing Spondylitis Market By Region, From 2019-2024 (USD Billion)
  177. Latin America Systemic Lupus Erythematosus (SLE) Market By Region, From 2019-2024 (USD Billion)
  178. Brazil Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  179. Argentina Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  180. Mexico Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  181. Middle East & Africa Autoimmune diagnostics Market By Region, From 2019-2024 (USD Billion)
  182. Middle East & Africa Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  183. Middle East & Africa Autoantibody Tests Market By Region, From 2019-2024 (USD Billion)
  184. Middle East & Africa Antinuclear Antibody Tests Market By Region, From 2019-2024 (USD Billion)
  185. Middle East & Africa Complete Blood Count (CBC) Market By Region, From 2019-2024 (USD Billion)
  186. Middle East & Africa C - reactive protein (CRP) Market By Region, From 2019-2024 (USD Billion)
  187. Middle East & Africa Comprehensive Metabolic panel Market By Region, From 2019-2024 (USD Billion)
  188. Middle East & Africa Urinalysis Market By Region, From 2019-2024 (USD Billion)
  189. Middle East & Africa Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2019-2024 (USD Billion)
  190. Middle East & Africa Other Test Types Market By Region, From 2019-2024 (USD Billion)
  191. Middle East & Africa Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  192. Middle East & Africa Localized Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  193. Middle East & Africa Systemic Autoimmune Diseases Diagnostics Market By Region, From 2019-2024 (USD Billion)
  194. Middle East Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  195. Middle East Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  196. Africa Autoimmune diagnostics Market By Test Type, From 2019-2024 (USD Billion)
  197. Africa Autoimmune diagnostics Market By Disease Type, From 2019-2024 (USD Billion)
  198. Middle East & Africa Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  199. Middle East & Africa Graves' Disease Market By Region, From 2019-2024 (USD Billion)
  200. Middle East & Africa Hashimoto's Thyroiditis Market By Region, From 2019-2024 (USD Billion)
  201. Middle East & Africa Multiple Sclerosis Market By Region, From 2019-2024 (USD Billion)
  202. Middle East & Africa Type 1 diabetes Market By Region, From 2019-2024 (USD Billion)
  203. Middle East & Africa Psoriasis Market By Region, From 2019-2024 (USD Billion)
  204. Middle East & Africa Other Localized Autoimmune Diagnostics Market By Region, From 2019-2024 (USD Billion)
  205. Middle East Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  206. Africa Localized Autoimmune Disease Diagnostics Market By Type, From 2019-2024 (USD Billion)
  207. Middle East & Africa Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  208. Middle East & Africa Rheumatoid Arthritis (RA) Market By Region, From 2019-2024 (USD Billion)
  209. Middle East & Africa Ankylosing Spondylitis Market By Region, From 2019-2024 (USD Billion)
  210. Middle East & Africa Systemic Lupus Erythematosus (SLE) Market By Region, From 2019-2024 (USD Billion)
  211. Middle East Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)
  212. Africa Systemic Auto-immune disease diagnostics Market By Type, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample